Stage III Grade 3 Follicular Lymphoma Completed Phase 0 Trials for Rituximab (DB00073)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0028630 (Stage III Grade 3 Follicular Lymphoma) | Completed | 0 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT00017381 | Monoclonal Antibody Therapy and Peripheral Stem Cell Transplant in Treating Patients With Non-Hodgkin's Lymphoma | Treatment |